Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial. (BMJ (Clinical research ed.), 2015)

(untitled) - Pace, D; Khatami, A; McKenna, J; Campbell, D; Attard-Montalto, S; Birks, J; Voysey, M; White, C; Finn, A; Macloed, E; Faust, S; Kent, A; et al.